Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia Lattanzi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Seminars in Immunology|March 19, 2022
Microbiota-targeted therapies in inflammation resolutionFrancesco Strati, Georgia Lattanzi, Chiara Amoroso, et al.
International Journal of Molecular Sciences|August 6, 2020
Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic PurposesFederica Perillo, Chiara Amoroso, Francesco Strati, et al.
Microbiome|February 7, 2021
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis modelsFrancesco Strati, Meritxell Pujolassos, Claudia Burrello, et al.
Molecular Oncology|September 18, 2021
Human intestinal and circulating invariant natural killer T cells are cytotoxic against colorectal cancer cells via the perforin-granzyme pathwayAngélica Díaz-Basabe, Claudia Burrello, Georgia Lattanzi, et al.
Kidney International|August 1, 2021
The circadian clock regulates rhythmic erythropoietin expression in the murine kidneyLina K Sciesielski, Matthias Felten, Laura Michalick, et al.
Journal of Crohn'S & Colitis|February 27, 2020
Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel DiseasesMarina Coletta, Moira Paroni, Maria Francesca Alvisi, et al.
Oncoimmunology|November 16, 2024
Estrogen-related differences in antitumor immunity and gut microbiome contribute to sexual dimorphism of colorectal cancerGeorgia Lattanzi, Federica Perillo, Angélica Díaz-Basabe, et al.
Developmental Cell|January 16, 2024
PCGF6 controls murine Tuft cell differentiation via H3K9me2 modification independently of Polycomb repressionAnnachiara Del Vecchio, Patrizia Mulé, Daniel Fernández-Pérez, et al.
Gut Microbes|August 12, 2024
<i>Porphyromonas gingivalis</i> fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasionAngélica Díaz-Basabe, Georgia Lattanzi, Federica Perillo, et al.
Journal of Crohn'S & Colitis|March 31, 2022
IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T LymphocytesClaudia Burrello, Francesco Strati, Georgia Lattanzi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Seminars in Immunology|March 19, 2022
Microbiota-targeted therapies in inflammation resolutionFrancesco Strati, Georgia Lattanzi, Chiara Amoroso, et al.
International Journal of Molecular Sciences|August 6, 2020
Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic PurposesFederica Perillo, Chiara Amoroso, Francesco Strati, et al.
Microbiome|February 7, 2021
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis modelsFrancesco Strati, Meritxell Pujolassos, Claudia Burrello, et al.
Molecular Oncology|September 18, 2021
Human intestinal and circulating invariant natural killer T cells are cytotoxic against colorectal cancer cells via the perforin-granzyme pathwayAngélica Díaz-Basabe, Claudia Burrello, Georgia Lattanzi, et al.
Kidney International|August 1, 2021
The circadian clock regulates rhythmic erythropoietin expression in the murine kidneyLina K Sciesielski, Matthias Felten, Laura Michalick, et al.
Journal of Crohn'S & Colitis|February 27, 2020
Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel DiseasesMarina Coletta, Moira Paroni, Maria Francesca Alvisi, et al.
Oncoimmunology|November 16, 2024
Estrogen-related differences in antitumor immunity and gut microbiome contribute to sexual dimorphism of colorectal cancerGeorgia Lattanzi, Federica Perillo, Angélica Díaz-Basabe, et al.
Developmental Cell|January 16, 2024
PCGF6 controls murine Tuft cell differentiation via H3K9me2 modification independently of Polycomb repressionAnnachiara Del Vecchio, Patrizia Mulé, Daniel Fernández-Pérez, et al.
Gut Microbes|August 12, 2024
<i>Porphyromonas gingivalis</i> fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasionAngélica Díaz-Basabe, Georgia Lattanzi, Federica Perillo, et al.
Journal of Crohn'S & Colitis|March 31, 2022
IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T LymphocytesClaudia Burrello, Francesco Strati, Georgia Lattanzi, et al.
Pageof 2